Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Mahajan

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
BMJ Open|May 2, 2022
COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort studyMadhumita Premkumar, Sekar Loganathan, Kamal Kajal, et al.
Clinical and Experimental Dental Research|July 12, 2022
Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal diseaseShipra Gupta, Ritin Mohindra, Mohita Singla, et al.
Cureus|January 17, 2022
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled TrialNaveen B Naik, Goverdhan D Puri, Kamal Kajal, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
BMJ Open|May 2, 2022
COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort studyMadhumita Premkumar, Sekar Loganathan, Kamal Kajal, et al.
Clinical and Experimental Dental Research|July 12, 2022
Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal diseaseShipra Gupta, Ritin Mohindra, Mohita Singla, et al.
Cureus|January 17, 2022
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled TrialNaveen B Naik, Goverdhan D Puri, Kamal Kajal, et al.
Pageof 4